Hepatitis C Module #1: The abCs of HCV

Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #3: HCV Drug Therapy Management

Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed. This activity is available for free to NASP members. Visit the top section of www.ProCE.com/CSPE for details.

IBD Module #1: Inflammatory Bowel Disease and the Role of Specialty Pharmacy Services

This activity addresses treatment goals, options for therapy, monitoring parameters and the pharmacist's role in IBD therapy management.

IBD Module #2: Medication and Patient Management

This educational activity reviews inflammatory bowel disease (IBD) treatment guidelines along with how to develop a treatment plan for the IBD patient.

Identify Gaps and Meeting the Needs of Antimicrobial Stewardship Research

This presentation discusses gaps in the stewardship literature, simple strategies for being successful in stewardship scholarship and potential roles for you as a mentor or mentee.

Implementing Change for Best Practices in Antimicrobial Stewardship

This activity will provide an overview of tools for planning and implementing new and existing antimicrobial stewardship programs.

Insights and Developments in HIV Treatment Strategies

This session will discuss strategies to identify patients at risk for HIV and implement screening guideline recommendations.

Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.